Two-Year VERASENSE™ Sensor-Assisted TKA Clinical Data to be Highlighted at 2015 American Academy of Orthopaedic Surgeons Annual Meeting

Dr. Gregory Golladay to Present New Data from Multicenter Evaluation at OrthoSensor Booth #455 on Thursday, March 26 

DANIA BEACH, FL (March 25, 2015) – OrthoSensor Inc., a leader in Sensor-Assisted Surgery, today announced that two-year postoperative data for its VERASENSE™ Sensor-Assisted TKA will be presented at the American Academy of Orthopaedic Surgeons (AAOS) 2015 Annual Meeting in Las Vegas’s Venetian/Sands EXPO Center. Dr. Gregory Golladay, Associate Professor at Virginia Commonwealth University and a leading specialist in knee and hip reconstruction who served as a lead investigator for the multicenter evaluation, will present the two-year data at 10:10 a.m. PT on Thursday, March 26, at the OrthoSensor booth #455. This data is a follow-up to six-month and one-year data previously published in peer-reviewed journals.

“We are excited to highlight VERASENSE™ at AAOS this year and look forward to demonstrating our technology’s ability to significantly improve soft tissue balance in total knee arthroplasty,” said Ivan Delevic, President and Chief Executive Officer of OrthoSensor.

Two-year results will include several patient-reported clinical outcomes including Knee Society Scores and Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC) scores, as well as patient-reported pain, functional and satisfaction outcomes. Results will be featured on OrthoSensor.com following the live booth presentation at the AAOS Annual Meeting.

About OrthoSensor, Inc.

OrthoSensor, Inc., a leader in Sensor-Assisted Total Knee Arthroplasty develops and commercializes intelligent orthopaedic devices and data services that provide quantitative feedback to surgeons and hospitals. The company’s intelligent orthopaedic devices utilize advanced proprietary sensor and communications technologies, coupled with the company’s innovative software products, to facilitate evidence-based decisions in orthopaedic surgery – with the goal of improving patient outcomes and potentially reducing the cost of treating musculoskeletal disease.

OrthoSensor® and VERASENSE™ are trademarks of OrthoSensor, Inc.

  • Facebook
  • Twitter
  • LinkedIN
  • Pinterest
Tagged in